Pharmaceuticals

Global Deoxycholic Acid Obesity Drugs Market Size Projected to Reach $0.85 Billion During the Forecast Period

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Deoxycholic Acid Obesity Drugs Market Expected To Expand Between 2025 And 2029?

The deoxycholic acid obesity drug market has experienced swift expansion in recent years. Its valuation is projected to increase from $0.44 billion in 2024 to $0.50 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.6%. The growth observed in the historical period can be ascribed to a heightened preference for minimally invasive procedures, a proliferation of aesthetic clinics and specialized treatment centers, consumers’ increasing willingness to invest in cosmetic and obesity treatments, a growing body of clinical evidence affirming the efficacy and safety of deoxycholic acid injections, and an rise in regulatory approvals and supportive policies in key markets.

The deoxycholic acid obesity drug market size is anticipated to experience substantial growth in the upcoming years. Its value is projected to reach $0.85 billion by 2029, achieving a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period is primarily driven by the rising prevalence of obesity, increasing demand for non-surgical fat reduction treatments, growing awareness of body aesthetics and cosmetic procedures, increased investment in research and development for new deoxycholic acid formulations, and the expanding availability of high-purity and combination therapy products. Significant trends for the forecast period include the advancement of combination therapies, innovations in medical technology and treatment protocols, technological progress in formulation, the integration of digital tools and artificial intelligence for treatment planning, and technological enhancements in injection lipolysis formulations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28192&type=smp

Which Drivers Are Impacting The Deoxycholic Acid Obesity Drugs Market?

The increasing prevalence of obesity is projected to boost the expansion of the deoxycholic acid obesity drug market moving forward. Obesity rates signify the percentage of individuals in a population categorized as overweight or obese based on their body mass index (BMI). The rise in obesity rates is largely attributed to poor dietary choices, such as frequent consumption of processed foods and sugary drinks, which results in the storage of excess calories as body fat. Deoxycholic acid obesity drugs assist in mitigating obesity by breaking down and eliminating surplus fat cells, leading to targeted fat reduction and improved body contours. For instance, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states registered an adult obesity rate of 35% or greater, up from 19 states in 2021. Thus, the escalating obesity rates are a key driver for the growth of the deoxycholic acid obesity drug market.

What Are The Major Segments Identified In The Deoxycholic Acid Obesity Drugs Market?

The deoxycholic acid obesity drugs market covered in this report is segmented as

1) By Drug Type: ATX-101 (Deoxycholic Acid Injection Or Kybella Or Belkyra), Experimental Or Compounded Deoxycholic Acid Formulations, Combination Therapies, Oral Deoxycholic Acid Products

2) By Formulation: Injectable, Topical

3) By Distribution Channel: Direct Sales, Retail Pharmacies, Online Pharmacies

4) By Application: Submental Fat Reduction, Abdominal Fat Reduction, Thighs Arms And Flanks, Lipomas And Localized Fat, Cellulite Management

5) By End-User: Aesthetic Clinics, Dermatology Clinics, Plastic Surgery Centers, Hospitals, Home Administration

Subsegments:

1) By ATX-101 (Deoxycholic Acid Injection or Kybella or Belkyra): Standard Injectable, High-Purity Formulations, Combination Injection Therapies

2) By Experimental Or Compounded Deoxycholic Acid Formulation: Clinical Trial Formulations, Compounded Customized Formulations

3) By Combination Therapies: Deoxycholic Acid + Lipolytic Agents, Deoxycholic Acid + Enzyme Therapy

4) By Oral Deoxycholic Acid Products: Capsules, Tablets, Liquid Formulations

Which Trends Are Impacting The Deoxycholic Acid Obesity Drugs Market?

Leading companies in the deoxycholic acid obesity drug market are concentrating on developing advanced products, such as injectable deoxycholic acid obesity drugs, to boost treatment effectiveness and improve patient outcomes. These injectable medications employ deoxycholic acid, a substance that breaks down fat cells, and are administered through injection to specifically target and reduce fat in particular areas. For instance, in March 2024, LG Chem Ltd., a chemicals company based in South Korea, unveiled Bellacholine, aimed at reducing submental fat. This nonsurgical injection is engineered to safely destroy fat cells using deoxycholic acid, thereby diminishing moderate to severe submental fat (double chin). It provides advantages like a body-compatible pH, minimal sedimentation, and enhanced skin elasticity through collagen synthesis.

Which Key Players Are Driving Competition In The Deoxycholic Acid Obesity Drugs Market?

Major companies operating in the deoxycholic acid obesity drugs market are AbbVie Inc., Cipla Ltd., Glenmark Life Sciences Limited, Curia Global Inc., Daewoong Pharmaceutical Co. Ltd., Actylis, ICE Pharma, Cayman Chemical Company, Nacalai Tesque Inc., Sichuan Huiyu Pharmaceutical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Jeevan Chemicals & Pharmaceuticals, Anhui Chem-Bright Bioengineering Co. Ltd., GlpBio Technology LLC, Legere Pharmaceuticals, Otto Chemie Pvt. Ltd., BOC Sciences, Guangzhou Green Cross Pharmaceutical, Prodotti Chimici e Alimentari S.P.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/deoxycholic-acid-obesity-drugs-global-market-report

Which Region Currently Holds The Largest Share Of The Deoxycholic Acid Obesity Drugs Market?

North America was the largest region in the deoxycholic acid obesity drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in deoxycholic acid obesity drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Deoxycholic Acid Obesity Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28192&type=smp

Browse Through More Reports Similar to the Global Deoxycholic Acid Obesity Drugs Market 2025, By The Business Research Company

Metabolic Disorders Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Weight Loss Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report

Weight Loss Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/weight-loss-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795